Free Trial

TFF Pharmaceuticals (TFFP) SEC Filings & 10K Form

$2.08
-0.13 (-5.88%)
(As of 05/29/2024 ET)

Recent TFF Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/14/2024
3:03 PM
TFF Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:04 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:13 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G
05/08/2024
3:26 PM
CARLSON CAPITAL L P (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G/A
05/06/2024
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
05/01/2024
9:54 AM
TFF Pharmaceuticals (Filer)
Form 424B4
04/29/2024
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
04/29/2024
6:15 AM
TFF Pharmaceuticals (Filer)
Form S-1/A
04/29/2024
5:06 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2024
3:32 PM
TFF Pharmaceuticals (Filer)
Form S-1/A
04/22/2024
7:49 PM
Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:49 PM
COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:50 PM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:51 PM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:52 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:52 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:53 PM
KING THOMAS BRAXTON (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:47 PM
TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
7:48 PM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2024
3:24 PM
TFF Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:24 PM
TFF Pharmaceuticals (Filer)
Form ARS
04/22/2024
3:19 PM
TFF Pharmaceuticals (Filer)
Form DEF 14A
04/22/2024
3:20 PM
TFF Pharmaceuticals (Filer)
Form DEFA14A
04/18/2024
4:20 PM
TFF Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/08/2024
5:41 AM
TFF Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/28/2024
3:05 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM
TFF Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
7:00 AM
TFF Pharmaceuticals (Filer)
Form 424B5
02/14/2024
5:48 PM
LYTTON LAURENCE W (Filed by)
TFF Pharmaceuticals (Subject)
Form SC 13G/A
12/19/2023
5:07 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
11:15 PM
TFF Pharmaceuticals (Filer)
Form EFFECT
12/08/2023
3:52 PM
TFF Pharmaceuticals (Filer)
Form S-3/A
12/04/2023
4:25 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2023
4:25 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2023
4:26 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
4:27 PM
Lee Catherine Chai-zon (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:28 PM
Patane Michael A (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:29 PM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:30 PM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
4:31 PM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:14 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
11/21/2023
3:41 PM
TFF Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2023
3:06 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/22/2023
3:16 PM
TFF Pharmaceuticals (Filer)
Form PRE 14A
09/18/2023
4:20 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
3:10 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
4:27 PM
Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/17/2023
4:29 PM
Asgard Investment Corp. II (Reporting)
CARLSON CAPITAL L P (Reporting)
Carlson Clint Duane (Reporting)
Double Black Diamond Offshore Ltd (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:43 PM
TFF Pharmaceuticals (Filer)
Form 424B5
08/15/2023
7:00 AM
Mikhak Zamaneh (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
MILLS ROBERT S (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
COLEMAN KIRK ALLEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
Roberts Brandi (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
ROCAMBOLI STEPHEN (Reporting)
TFF Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
7:00 AM
TFF Pharmaceuticals (Issuer)
Weisman Harlan F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
5:11 AM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
5:02 AM
TFF Pharmaceuticals (Filer)
Form 424B5
06/23/2023
4:18 PM
TFF Pharmaceuticals (Filer)
Form 424B5
06/23/2023
4:15 PM
TFF Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TFFP) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners